Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Two Drugs ,i.e., Nalbuphine Vs Ketamine at Low Doses for the Peri-Operative Shivering Control in Patients Undergoing Gynaecological Surgery Under Spinal Anaesthesia
Sponsor: Sargodha Medical College
Summary
Shivering is recognized as an undesirable effect of spinal anesthesia. Patients undergoing gynecological surgeries may experience increased physiological stress due to perioperative shivering. This condition can lead to serious complications such as increased oxygen consumption, resulting in hypoxemia, lactic acidosis, and elevated carbon dioxide production. Additionally, shivering may cause increased intraocular and intracerebral pressure and can interfere with monitoring techniques like pulse oximetry, blood pressure, and electrocardiography. If not treated, shivering can negatively impact patient outcomes, prolong recovery times, and extend hospital stays. The use of opioids has shown effectiveness in treating shivering. Based on the existing literature, it is hypothesized that there is no difference in the efficacy of nalbuphine and ketamine in controlling perioperative shivering in patients undergoing gynecological surgery under spinal anesthesia. Therefore, the study aims to investigate and compare the effectiveness of nalbuphine and ketamine in managing post-spinal shivering in these patients, focusing on i) incidence of shivering, ii) severity of shivering in both groups, iii) complications such as vomiting and sedation, and iv) the need for rescue medication. Preventing and managing shivering is crucial for successful surgical outcomes. To date, no comparative study has evaluated the intravenous efficacy of these two drugs in this patient population for post-spinal shivering control. This will be a double-blind, randomized controlled trial conducted in the Anesthesiology Department at DHQ Teaching Hospital Sargodha. A total of 90 gynecological patients will be enrolled and divided equally into two groups: Group N receiving nalbuphine and Group K receiving ketamine. Parameters such as heart rate, systolic and diastolic blood pressure, temperature, oxygen saturation, incidence and grade of shivering, complications like sedation and vomiting, and the need for rescue medication will be recorded. The study may face limitations due to the lack of advanced monitoring equipment for assessing parameters like core body temperature at the study site. Evaluations of cognitive and psychomotor functions cannot be conducted due to resource constraints. The use of a non-probability convenience sampling method, while practical, may introduce bias. Additionally, precise blinding may not be achievable due to limited technical personnel, and financial constraints prevent increasing the sample size.
Official title: Comparison of Nalbuphin vs Ketamine for the Control of Peri-operative Shivering in Patients Undergoing Gynaecological Surgery Under Spinal Anaesthesia
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2023-04-01
Completion Date
2024-02-01
Last Updated
2026-04-22
Healthy Volunteers
Yes
Interventions
Participants assigned to this arm received injection nalbuphine.
After spinal anesthesia in a sitting position at L3-L4 or L4-L5 using a 25-gauge Quincke spinal needle, 1.2 mL of 0.75% (7.5 mg) hyperbaric bupivacaine was injected in the subarachnoid space. The Bromage scale and cold test by using a spirit swab will be used to evaluate the subarachnoid block for the desired motor and sensory blocks, respectively. After spinal anesthesia, the study drug Nalbuphin (0.07 mg/kg) will be administered intravenously to group N, and oxygen will be given through a face mask at 4 liters per minute.
Participants assigned to this arm received injection ketamine.
After spinal anesthesia in a sitting position at L3-L4 or L4-L5 using a 25-gauge Quincke spinal needle, 1.2 mL of 0.75% (7.5 mg) hyperbaric bupivacaine was injected into the subarachnoid space. The Bromage scale and cold test by using a spirit swab will be used to evaluate the subarachnoid block for the desired motor and sensory blocks, respectively. After spinal anesthesia, the study drug ketamine (0.2 mg/kg) will be administered intravenously to group N, and oxygen will be given through a face mask at 4 liters per minute.
Locations (1)
DHQ
Sargodha, Pakistan